Literature DB >> 33450808

Mechanical Loading-Driven Tumor Suppression Is Mediated by Lrp5-Dependent and Independent Mechanisms.

Yan Feng1,2, Shengzhi Liu2, Rongrong Zha1,2, Xun Sun1,2, Kexin Li1,2, Alexander Robling3,4, Baiyan Li1, Hiroki Yokota1,2,3,4,5.   

Abstract

Bone is mechanosensitive and lipoprotein receptor-related protein 5 (Lrp5)-mediated Wnt signaling promotes loading-driven bone formation. While mechanical loading can suppress tumor growth, the question is whether Lrp5 mediates loading-driven tumor suppression. Herein, we examined the effect of Lrp5 using osteocyte-specific Lrp5 conditional knockout mice. All mice presented noticeable loading-driven tumor suppression in the loaded tibia and non-loaded mammary pad. The degree of suppression was more significant in wild-type than knockout mice. In all male and female mice, knee loading reduced cholesterol and elevated dopamine. It reduced tumor-promoting nexin, which was elevated by cholesterol and reduced by dopamine. By contrast, it elevated p53, TNF-related apoptosis-inducing ligand (TRAIL), and chemerin, and they were regulated reversely by dopamine and cholesterol. Notably, Lrp5 overexpression in osteocytes enhanced tumor suppression, and osteoclast development was inhibited by chemerin. Collectively, this study identified Lrp5-dependent and independent mechanisms for tumor suppression. Lrp5 in osteocytes contributed to the loaded bone, while the Lrp5-independent regulation of dopamine- and cholesterol-induced systemic suppression.

Entities:  

Keywords:  Lrp5; breast cancer; chemerin; mechanical stimulation; nexin; osteocyte; prostate cancer

Year:  2021        PMID: 33450808     DOI: 10.3390/cancers13020267

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  4 in total

1.  Preventing tumor progression to the bone by induced tumor-suppressing MSCs.

Authors:  Xun Sun; Kexin Li; Rongrong Zha; Shengzhi Liu; Yao Fan; Di Wu; Misato Hase; Uma K Aryal; Chien-Chi Lin; Bai-Yan Li; Hiroki Yokota
Journal:  Theranostics       Date:  2021-03-05       Impact factor: 11.600

2.  Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.

Authors:  Xun Sun; Kexin Li; Misato Hase; Rongrong Zha; Yan Feng; Bai-Yan Li; Hiroki Yokota
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

3.  LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer.

Authors:  Xiaobo Nie; Huiyang Liu; Wenling Ye; Xiaoyun Wei; Lili Fan; Han Ma; Lanqing Li; Wanting Xue; Wenting Qi; Yan-Dong Wang; Wei-Dong Chen
Journal:  J Cell Mol Med       Date:  2022-01-07       Impact factor: 5.310

Review 4.  Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer.

Authors:  Sarah Koushyar; Valerie S Meniel; Toby J Phesse; Helen B Pearson
Journal:  Biomolecules       Date:  2022-02-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.